tomeko

Autosomal dominant Charcot-Marie-Tooth disease type 2W

Just diagnosed with Autosomal dominant Charcot-Marie-Tooth disease type 2W?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Autosomal dominant Charcot-Marie-Tooth disease type 2W, look for clinical trials, and connect with others living with it — all in one place.

Open the full Autosomal dominant Charcot-Marie-Tooth disease type 2W hub →

Overview

Autosomal dominant Charcot-Marie-Tooth disease type 2W is a rare condition. Also known as Autosomal dominant Charcot-Marie-Tooth disease type 2 due to HARS mutation, CMT2W. Tomeko brings together the specialists, research, clinical trials, treatments and community for Autosomal dominant Charcot-Marie-Tooth disease type 2W so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:488333 · OMIM 616625 · ICD-10 G60.0 · GARD 0017891

Find care for Autosomal dominant Charcot-Marie-Tooth disease type 2W

Authoritative references for Autosomal dominant Charcot-Marie-Tooth disease type 2W

Common questions

I was just diagnosed with Autosomal dominant Charcot-Marie-Tooth disease type 2W — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Autosomal dominant Charcot-Marie-Tooth disease type 2W, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Autosomal dominant Charcot-Marie-Tooth disease type 2W?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Autosomal dominant Charcot-Marie-Tooth disease type 2W, filtered to your area.

Are there clinical trials for Autosomal dominant Charcot-Marie-Tooth disease type 2W?

Tomeko shows live, recruiting studies for Autosomal dominant Charcot-Marie-Tooth disease type 2W from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com